
Share
OpenAI teams up with Broadcom to create a bespoke AI chip, aiming to enhance performance and reduce dependency on third-party suppliers, marking a pivotal shift in the tech giant's approach to hardware development.
OpenAI, the company behind the popular generative AI model ChatGPT, is set to produce its first in-house artificial intelligence (AI) chip next year in collaboration with U.S. semiconductor giant Broadcom, according to a report from the Financial Times. This move marks a significant step toward reducing OpenAI's reliance on external suppliers and optimizing its hardware for internal use.
For AI practitioners, this development is crucial for several reasons:

OpenAI has been at the forefront of generative AI, developing models capable of producing human-like responses. However, these models require substantial computing power to train and run effectively. By developing its own chips, OpenAI aims to address the following challenges:
OpenAI's decision to develop its first AI chip with Broadcom is a strategic move aimed at enhancing their internal capabilities and reducing costs. This partnership could set a precedent for other AI companies looking to gain more control over their hardware infrastructure. As the project progresses, we can expect to see further details on the chip's architecture and performance benchmarks.
Tags
Original Sources
About the author
Kai built ML infrastructure at a Bay Area startup before developing an obsession with transformer architectures and inference optimisation that eventually pulled him out of product work entirely. A stint at a compute research lab sharpened his instinct for what actually matters in a model release versus what is marketing. He writes from the inside — from the perspective of someone who has debugged the systems he is describing at three in the morning. He is allergic to hype and instinctively drawn to the unglamorous plumbing questions that everyone else skips over.
More from The Engineer →This Week's Edition
5 September 2025
88 articles
Related Articles

OpenEvidence Targets Hospitals to Expand Its AI Chatbot for Doctors
Products & Applications · 3 min

OpenEvidence Launches Voice AI to Enhance Physician Workflow
Products & Applications · 3 min

Doximity Accelerates AI Investment in 2026, Targeting Multibillion-Dollar Market
Products & Applications · 3 min
Related Articles

OpenEvidence Targets Hospitals to Expand Its AI Chatbot for Doctors
Products & Applications · 3 min

OpenEvidence Launches Voice AI to Enhance Physician Workflow
Products & Applications · 3 min

Doximity Accelerates AI Investment in 2026, Targeting Multibillion-Dollar Market
Products & Applications · 3 min
More Stories